MAPT and Alzheimer disease: The currently most accepted model indicates that Aβ pathophysiology may be an upstream pathophysiological event in AD and may function as a trigger/facilitator of downstream molecular pathways, including tau misfolding, tau-mediated toxicity, accumulation in tangles, and tau spreading that leads to cortical neurodegeneration (see Fig. 5) [218–222].